%0 Journal Article
%T [Hematopoietic stem cell transplantation ocular complications: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
%A Borel C
%A Ahmad I
%A Ceballos P
%A Desbrosses Y
%A Hamzy F
%A Ravinet A
%A Souchet L
%A Turlure P
%A Villate A
%A Yakoub-Agha I
%A Guillaume T
%J Bull Cancer
%V 107
%N 12
%D Dec 2020
%M 32631612
%F 1.318
%R 10.1016/j.bulcan.2020.04.014
%X BACKGROUND: Allogeneic stem cell transplantation is currently the only curative therapy for hematological disorders. This treatment can lead to complications, of which ophtalmological involvement.
METHODS: We reviewed the literature and established accessible and convenient recommendations for hematologists and ophthalmologists.
RESULTS: Ophtalmological follow-up should be done in every patient having had an allogeneic transplantation, by the hematologist questioning and by the ophthalmologist physical exam. Complications due to graft-versus-host disease (GVHD) or not due to GVHD are cited, as well as therapeutic options.
CONCLUSIONS: Screening and treatment of ophthalmologic complications in allogeneic stem cells transplantation recipients requires a close collaboration between hematologists and ophthalmologists. The management of these patients by caregivers trained in these questions is encouraged.